Veradermics, Inc. (MANE)
115.44
-0.28
(-0.24%)
USD |
NYSE |
Sep 25, 10:39
Veradermics Market Cap : 4.823B for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 24, 2026 | 4.835B |
| September 23, 2026 | 4.837B |
| September 22, 2026 | 4.936B |
| September 21, 2026 | 4.713B |
| September 18, 2026 | 4.460B |
| September 17, 2026 | 4.541B |
| September 16, 2026 | 4.279B |
| September 15, 2026 | 4.341B |
| September 14, 2026 | 4.249B |
| September 11, 2026 | 4.135B |
| September 10, 2026 | 4.100B |
| September 09, 2026 | 4.164B |
| September 08, 2026 | 4.338B |
| September 04, 2026 | 4.116B |
| September 03, 2026 | 4.084B |
| September 02, 2026 | 4.114B |
| September 01, 2026 | 4.074B |
| August 31, 2026 | 4.112B |
| August 28, 2026 | 4.092B |
| August 27, 2026 | 4.254B |
| August 26, 2026 | 4.295B |
| August 25, 2026 | 4.276B |
| August 24, 2026 | 4.114B |
| August 21, 2026 | 4.296B |
| August 20, 2026 | 4.400B |
| Date | Value |
|---|---|
| August 19, 2026 | 4.647B |
| August 18, 2026 | 4.651B |
| August 17, 2026 | 4.521B |
| August 14, 2026 | 4.709B |
| August 13, 2026 | 4.638B |
| August 12, 2026 | 4.556B |
| August 11, 2026 | 4.552B |
| August 10, 2026 | 4.627B |
| August 07, 2026 | 4.779B |
| August 06, 2026 | 4.539B |
| August 05, 2026 | 4.157B |
| August 04, 2026 | 4.006B |
| August 03, 2026 | 3.805B |
| July 31, 2026 | 3.921B |
| July 30, 2026 | 3.907B |
| July 29, 2026 | 4.024B |
| July 28, 2026 | 4.165B |
| July 27, 2026 | 4.160B |
| July 24, 2026 | 4.089B |
| July 23, 2026 | 4.326B |
| July 22, 2026 | 4.102B |
| July 21, 2026 | 4.088B |
| July 20, 2026 | 3.960B |
| July 17, 2026 | 4.157B |
| July 16, 2026 | 3.952B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.098T |
| EyePoint, Inc. | 305.08M |
| Elanco Animal Health, Inc. | 11.10B |
| Amylyx Pharmaceuticals, Inc. | 3.335B |
| ANI Pharmaceuticals, Inc. | 1.692B |
Market Cap Related Metrics
| PEG Ratio | -0.1257 |
| Price to Book Value | 5.924 |
| Price | 115.44 |
| Earnings Yield | -2.26% |
| PEGY Ratio | -0.1257 |